CVRx, Inc. Files 8-K Report
Ticker: CVRX · Form: 8-K · Filed: Nov 4, 2024 · CIK: 1235912
| Field | Detail |
|---|---|
| Company | Cvrx, Inc. (CVRX) |
| Form Type | 8-K |
| Filed Date | Nov 4, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01, $45,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, 8-k
Related Tickers: CVRX
TL;DR
CVRx filed an 8-K, check for news.
AI Summary
On November 4, 2024, CVRx, Inc. filed an 8-K report detailing an "Other Event." The filing does not contain specific financial figures or new material information beyond the reporting of an event.
Why It Matters
This filing indicates a regulatory update from CVRx, Inc., requiring investors to check for any material disclosures that may impact the company's stock.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for an 'Other Event' and does not disclose specific financial or operational changes that would immediately impact risk.
Key Players & Entities
- CVRx, Inc. (company) — Registrant
- November 4, 2024 (date) — Date of report
FAQ
What is the specific nature of the 'Other Event' reported by CVRx, Inc. on November 4, 2024?
The filing does not specify the nature of the 'Other Event'; it is a placeholder for events not covered by other 8-K items.
Does this 8-K filing contain any financial updates for CVRx, Inc.?
No, this 8-K filing does not contain specific financial updates or figures.
What is the primary purpose of an 8-K filing for an 'Other Event'?
An 8-K filing for an 'Other Event' is used to report any events that the company considers to be of importance to its security holders but do not fit into the other categories of 8-K reporting.
What is CVRx, Inc.'s principal executive office address?
CVRx, Inc.'s principal executive offices are located at 9201 West Broadway Avenue, Suite 650, Minneapolis, MN 55445.
What is CVRx, Inc.'s telephone number?
CVRx, Inc.'s telephone number is (763) 416-2840.
Filing Stats: 412 words · 2 min read · ~1 pages · Grade level 10.7 · Accepted 2024-11-04 08:07:55
Key Financial Figures
- $0.01 — ich registered Common stock, par value $0.01 per share CVRX The Nasdaq Global S
- $45,000 — 1580. The APC payment of approximately $45,000 will continue in 2025, as published in
Filing Documents
- tm2427376d1_8k.htm (8-K) — 23KB
- 0001104659-24-113676.txt ( ) — 193KB
- cvrx-20241104.xsd (EX-101.SCH) — 3KB
- cvrx-20241104_lab.xml (EX-101.LAB) — 33KB
- cvrx-20241104_pre.xml (EX-101.PRE) — 22KB
- tm2427376d1_8k_htm.xml (XML) — 4KB
01. Other Events
Item 8.01. Other Events. On November 4, 2024, CVRx, Inc. (the "Company") announced that the Centers for Medicare and Medicaid Services assigned the Barostim procedure to New Technology Ambulatory Payment Classification (APC) 1580. The APC payment of approximately $45,000 will continue in 2025, as published in the 2025 Medicare Hospital Outpatient Prospective Payment System final rule.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CVRx, Inc. Date: November 4, 2024 By: /s/ Jared Oasheim Name: Jared Oasheim Its: Chief Financial Officer